Patents by Inventor Einat Zalckvar

Einat Zalckvar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1
    Publication number: 20140178899
    Abstract: The present invention relates to antibodies specific for human Beclin-1 protein phosphorylated at position Thr 119 and uses thereof. In particular, these antibodies are useful in diagnosing diseases associated with impaired autophagy including cancer and neurodegenerative diseases. The invention further relates to human Beclin-1 mutated at position 119 with a phospho-mimicking residue and uses thereof for treating cancer and neurodegenerative diseases.
    Type: Application
    Filed: December 12, 2013
    Publication date: June 26, 2014
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Adi Kimchi, Einat Zalckvar
  • Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1
    Patent number: 8436145
    Abstract: The present invention relates to antibodies specific for human Beclin-1 protein phosphorylated at position Thr 119 and uses thereof. In particular, these antibodies are useful in diagnosing diseases associated with impaired autophagy including cancer and neurodegenerative diseases. The invention further relates to human Beclin-1 mutated at position 119 with a phospho-mimicking residue and uses thereof for treating cancer and neurodegenerative diseases.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: May 7, 2013
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Adi Kimchi, Einat Zalckvar
  • COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1
    Publication number: 20110301093
    Abstract: The present invention relates to antibodies specific for human Beclin-1 protein phosphorylated at position Thr 119 and uses thereof. In particular, these antibodies are useful in diagnosing diseases associated with impaired autophagy including cancer and neurodegenerative diseases. The invention further relates to human Beclin-1 mutated at position 119 with a phospho-mimicking residue and uses thereof for treating cancer and neurodegenerative diseases.
    Type: Application
    Filed: June 3, 2011
    Publication date: December 8, 2011
    Applicant: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Adi Kimchi, Einat Zalckvar
  • COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RELATED TO BECLIN-1
    Publication number: 20110300559
    Abstract: The present invention relates to antibodies specific for human Beclin-1 protein phosphorylated at position Thr 119 and uses thereof. In particular, these antibodies are useful in diagnosing diseases associated with impaired autophagy including cancer and neurodegenerative diseases. The invention further relates to human Beclin-1 mutated at position 119 with a phospho-mimicking residue and uses thereof for treating cancer and neurodegenerative diseases.
    Type: Application
    Filed: June 3, 2011
    Publication date: December 8, 2011
    Applicant: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Adi Kimchi, Einat Zalckvar
  • COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER AND NEURODEGENERATIVE DISEASES RLATED TO BECLIN-1
    Publication number: 20110229905
    Abstract: The present invention relates to antibodies specific for human Beclin-1 protein phosphorylated at position Thr 119 and uses thereof. In particular, these antibodies are useful in diagnosing diseases associated with impaired autophagy including cancer and neurodegenerative diseases. The invention further relates to human Beclin-1 mutated at position 119 with a phospho-mimicking residue and uses thereof for treating cancer and neurodegenerative diseases.
    Type: Application
    Filed: December 6, 2009
    Publication date: September 22, 2011
    Applicant: Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Adi Kimchi, Einat Zalckvar